Acetylcarnitine

Acetylcarnitine

SCHEMBL69781

CC(=O)OC(CC(=O)[O-])C[N+](C)(C)C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 1.00
KMT2A Q03164 3/20 1.00
CYP1A2 P05177 1/20 1.00
HRH1 P35367 1/20 1.00
CYP2C19 P33261 2/20 0.69
RECQL P46063 1/20 0.69
SMN1; SMN2 Q16637 2/20 0.68
LMNA P02545 1/20 0.68
SLC25A20 O43772 3/20 0.58
TSHR P16473 3/20 0.58
TP53 P04637 2/20 0.58
CYP2D6 P10635 2/20 0.58
MAPT P10636 2/20 0.58
SLC6A5 Q9Y345 2/20 0.58
KDM4E B2RXH2 1/20 0.58
CYP3A4 P08684 1/20 0.58
CYP2C9 P11712 1/20 0.58
NFKB1 P19838 1/20 0.58
THPO P40225 1/20 0.58
HIF1A Q16665 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetylcarnitine SCHEMBL677128 1.00 MEN1 (1.00) MEN1KMT2ACYP1A2HRH1CYP2C19
Acetylcarnitine SCHEMBL118455 1.00 MEN1 (1.00) MEN1KMT2ACYP1A2HRH1CYP2C19
Acetylcarnitine SCHEMBL28017793 1.00 MEN1 (1.00) MEN1KMT2ACYP1A2HRH1CYP2C19
Acetylcarnitine SCHEMBL3004014 0.98 MEN1 (0.96) MEN1KMT2ACYP1A2HRH1CYP2C19
Acetylcarnitine SCHEMBL1331768 0.98 MEN1 (0.96) MEN1KMT2ACYP1A2HRH1CYP2C19
Acetylcarnitine SCHEMBL1330152 0.98 MEN1 (0.96) MEN1KMT2ACYP1A2HRH1CYP2C19
Acetylcarnitine SCHEMBL9300885 0.98 MEN1 (0.96) MEN1KMT2ACYP1A2HRH1CYP2C19
Acetylcarnitine SCHEMBL387375 0.98 MEN1 (0.96) MEN1KMT2ACYP1A2HRH1CYP2C19
Acetylcarnitine SCHEMBL4378230 0.98 MEN1 (0.96) MEN1KMT2ACYP1A2HRH1CYP2C19
Acetylcarnitine SCHEMBL951660 0.98 MEN1 (0.96) MEN1KMT2ACYP1A2HRH1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 7539 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260148848-A1 BIOMARKERS FOR DIAGNOSIS AND TREATMENT OF ENDOCRINE HYPERTENSION, AND METHODS OF IDENTIFICATION THEREOF INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) 2026-05-28 US claimed
US-20260146992-A1 INTESTINAL BIOMARKERS FOR GUT HEALTH IN DOMESTICATED BIRDS INTERNATIONAL N&H DENMARK APS (DK) 2026-05-28 US claimed
US-20260146298-A1 INTESTINAL BIOMARKERS FOR GUT HEALTH IN DOMESTICATED BIRDS INTERNATIONAL N&H DENMARK APS (DK) 2026-05-28 US claimed
CN-122081073-A Excrement fungus cryopreservation liquid and application thereof 2026-05-26 CN claimed
US-20260137616-A1 Skincare Composition Utilizing a Metabolomics Guided, Bioprocess Engineered Sunflower Sprout Active JAMRM LLC (US) 2026-05-21 US claimed
CN-122056386-A Moisture absorption resistant slow release microcapsule powder and preparation method and application thereof 大连医诺生物股份有限公司 2026-05-19 CN claimed
CN-122030612-A Shear-resistant slow-release microcapsule powder and preparation method and application thereof 大连医诺生物股份有限公司 2026-05-15 CN claimed
US-20260130850-A1 TRANSDERMAL DELIVERY FORMULATIONS AND METHODS FOR THE MANUFACTURE THEREOF LIFEACTIVE INC (US) 2026-05-14 US claimed
EP-3869192-B1 METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE HUMAN METABOLOMICS INST INC (CN) 2026-05-13 EP claimed
CN-119421945-B Maturation medium compositions and methods for human cardiac organoids maturation 密歇根州立大学董事会 2026-05-12 CN claimed
EP-0215697-A2 Acylcarnitines as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal compartments MERCK & CO. INC. (US) 1987-03-25 EP claimed
EP-0207011-A2 Use of some alkanoyl L-carnitines for the manufacture of a medicament for therapeutical treatment of idiopathic and induced Parkinsonism Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 1986-12-30 EP claimed
US-4599232-A Pharmaceutical composition with metabolic and energetic activity for the use in cardiac and vascular therapy SIGMA TAU INDUSTRIE FARAMACEUTICHE RIUNITE S.P.A. (IT) 1986-07-08 US claimed
EP-0162764-A1 Composition and method for enhancing absorption of drugs from gastrointestinal tract using acylcarnitines MERCK & CO. INC. (US) 1985-11-27 EP claimed
US-4537772-A Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines MERCK & CO., INC. (US) 1985-08-27 US claimed
US-4415589-A Use of carnitine and of lower acyl-carnitines in the therapeutic treatment of the pathology of the veins SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 1983-11-15 US claimed
US-4415588-A ACETYLCARNITINE; STIMULANTS; IMMUNOLOGY SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 1983-11-15 US claimed
US-4330557-A UPGRADING METABOLIC OXIDATION OF FATTY ACIDS IN HUMANS CAVAZZA CLAUDIO 1982-05-18 US claimed
US-4268524-A Method of treating abnormal lipoprotein ratios with acylcarnitine CAVAZZA CLAUDIO 1981-05-19 US claimed
US-4194006-A ANTIARRHYTHMIA CAVAZZA CLAUDIO (IT) 1980-03-18 US claimed